SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Zim Integrated Shipping Services is trending amidst reports of a $4.2 billion acquisition offer from Hapag-Lloyd, sparking community debate over the company's valuation after its board rejected a lower internal offer, fueling speculation about potential bidding wars and a short squeeze, while facing scrutiny from the Israeli government and union regarding foreign ownership.

Sperax is redefining financial autonomy through programmable agents that manage capital, optimize yield, and protect against risk, all transparently on-chain. Founded in 2019, Sperax is backed by leading investors including Jump Trading, Polychain Capital, Amber Group. Sperax offers a new standard in automated, user-driven finance.  The SperaxOS ecosystem is powered by USDs and SPA on Arbitrum, BNB Chain, and other EVM networks. Anchored by two native assets: USDs, a gas-free, auto-yield stablecoin backed by on-chain collateral, and SPA, the governance and value-capture token. Sperax builds open-source tools that turn idle capital into self-optimizing portfolios.  SperaxOS is a cross-chain financial operating system where AI-driven smart agents automate everything from yield farming to payroll, and Demeter, a no-code platform for launching liquidity farms. USDs automatically rebases yield to holders, while SPA lets users register agents, earn protocol fees, and vote on upgrades. Battle-tested through multiple market cycles: Sperax offers individuals, DAOs, and fintechs a borderless toolkit for passive income, risk-managed investing, and fully automated treasury operations, all governed on-chain by its community.

Sperax

Sperax ($SPA) is trending with unusual trading volume as the community actively accumulates tokens, anticipating the imminent launch of SperaxOSan AI-powered yield system based on its compliant stablecoin, $USDswhich many believe positions it favorably amidst evolving stablecoin regulations and potential Tier 1 exchange listings.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is trending as community conversation intensifies around the recently completed Renergen acquisition and the anticipated QLE spin-off, with many eager for updates on commercial isotope shipments amid broader sector momentum in critical materials and nuclear energy.

Chubb Ltd. operates as a holding company, which engages in the provision of commercial and personal property and casualty insurance, personal accident and accident and health (A&H), reinsurance, and life insurance. It operates through the following segments: North America Commercial Property and Casualty (P&C) Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Corporate. The North America Commercial P&C Insurance segment that includes the business written by Chubb divisions that provide P&C insurance and services to large, middle market and small commercial businesses in the U.S., Canada, and Bermuda. The North America Personal P&C Insurance segment offers affluent and high net worth individuals and families with homeowners, high value automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The North America Agricultural Insurance segment is involved in comprehensive multiple peril crop insurance (MPCI) and crop-hail insurance, and Chubb agribusiness. The Overseas General Insurance segment caters for both commercial and consumer P&C insurance and services in countries and territories outside of North America where the company operates. The Global Reinsurance segment covers the reinsurance business. The Corporate segment focuses on the results of non-insurance companies, income, and expenses not attributable to reportable segments. The company was founded in 1882 and is headquartered in Zurich, Switzerland.

Chubb Limited

Chubb is actively discussed for its recent bond issuance related to former President Trump, generating polarized community sentiment regarding its financial impact and corporate image. This comes as the company reports strong underlying earnings and an optimistic outlook, balancing continued growth with ongoing concerns over catastrophe losses impacting the insurance sector.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance (AERO) is rallying amidst its Robinhood listing, driving community discussions around its role as Base's central liquidity hub and the implications of its anticipated merger into a "MetaDEX," while its revenue generation model is debated against other major DEXs.

Direxion Shares ETF Trust - Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares

KORU is trending sharply higher, fueled by South Korea's new short-selling ban until June 2024 and its underlying strength from semiconductor giants like Samsung and SK Hynix, whose dominance in HBM and memory super cycles has the community calling it a 'monster runner' among leveraged ETFs.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

VVV is trending as significant token supply reductions via burns and decreased emission rates, coupled with surging platform activity for its private and uncensored AI inference, fuels community speculation about a major breakout in the AI sector.

Wix.com Ltd. engages in providing a web development platform for creators, delivering its solutions through a Software-as-a-Service model. Its products include website templates, website builder, website design, Wix features, app market, web hosting, domain names, website accessibility, mobile app builder, and AI website builder. The company was founded by Avishai Abrahami, Nadav Abrahami, Nir Zohar, and Giora Kaplan on October 5, 2006 and is headquartered in Tel Aviv, Israel.

Wix.com Ltd

Wix.com is a hot topic following its multi-billion dollar share repurchase program and aggressive AI integration, sparking a fierce debate among investors. Bulls view the company as an undervalued AI innovator ripe for a short squeeze or even a Google acquisition, while bears contend its website builder business is rapidly being rendered obsolete by free AI alternatives.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Strong institutional interest, evidenced by an oversubscribed private placement, and the commencement of drilling for its KRONOS MMR microreactor prototype with the University of Illinois are driving conversation around Nano Nuclear Energy. While supporters see these milestones as validating its potential in meeting AI's surging energy demands, community discussion also reflects caution regarding its pre-revenue status and speculative valuation in the advanced nuclear sector.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is generating buzz as its dedicated community, fueled by "pure meme culture" and strong conviction, anticipates a major surge in the burgeoning Solana memecoin season. Holders are actively "spreading the virus," viewing any dips as generational buying opportunities for its inevitable "takeover."

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Downgrades Royalty Pharma (NASDAQ:RPRX) to Buy

Wall Street Zen downgraded shares of Royalty Pharma from a "strong-buy" rating to a "buy" rating in a report on Saturday...

New South Capital Management Inc. Purchases 31,694 Shares of Royalty Pharma PLC $RPRX

New South Capital Management Inc. lifted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 1.1% in the 3rd quarter, according to the company in its most recent disclosure with the...

Cookson Peirce & Co. Inc. Buys 338,623 Shares of Royalty Pharma PLC $RPRX

Cookson Peirce & Co. Inc. raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 988.3% during the 3rd quarter, according to the company in its most recent filing with the...

Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year High - Here's What Happened

Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Should You Buy...

Royalty Pharma (NASDAQ:RPRX) Releases Earnings Results, Misses Expectations By $0.90 EPS

Royalty Pharma (NASDAQ:RPRX - Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported $0.38 earnings per share for the quarter, missing the...

Royalty Pharma Q4 Earnings Call Highlights

Royalty Pharma (NASDAQ:RPRX) executives highlighted what they described as a landmark year in 2025, pointing to double-digit top-line growth, continued capital deployment into new royalty deals, and...

Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q4 Earnings

While the top- and bottom-line numbers for Royalty Pharma (RPRX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Royalty Pharma Plc Bottom Line Advances In Q4

(RTTNews) - Royalty Pharma plc (RPRX) announced earnings for its fourth quarter that Increased from the same period last year...

Royalty Pharma Q4 Earnings Report: What Investors Need to Know

Exploring Analyst Estimates for Royalty Pharma (RPRX) Q4 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Royalty Pharma (RPRX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Royalty Pharma plc - Ordinary Shares - Class A

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RPRX News

RPRXRoyalty Pharma plc - Ordinary Shares - Class A